AnalystsRobin GarnerRobin Garner's Stock Forecasts
AnalystsRobin Garner
Sectors:
Industries:
Analyst Ranking
Bottom 12%
#4056 out of 4586 analysts
Average Return
-40.8%
Win Rate
0%0 out of 6
Risk vs Reward
Poor
Good
Robin Garner's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
No Ratings AvailableRobin Garner doesn't have any winning ratings in our database | |||||
Robin Garner Analyst Color
Get additional color on Robin Garner's coverage of popular stocks
Robin Garner's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Xeris Biopharma Holdings IncXERS | 2 | Buy | $4.50 | +127.27% | Initiates Coverage On | 9 months ago |
Cue Biopharma IncCUE | 1 | Buy | $26.00 | N/A | Maintains | 2 years ago |
Landos Biopharma IncLABP | 1 | Buy | $450.00 | N/A | Initiates Coverage On | 3 years ago |
Trillium Therapeutics IncTRIL | 1 | Hold | $18.50 | N/A | Downgrades | 3 years ago |
Forma Therapeutics Holdings IncFMTX | 1 | Buy | $58.00 | N/A | Initiates Coverage On | 3 years ago |
Fennec Pharmaceuticals IncFENC | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.